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225 Education for physiotherapeutic caregivers of patients with
cystic ﬁbrosis
T. Andrade1,2, B. Guitton1, E. Monteiro2, V. Deolindo2. 1Universidade Federal
Fluminense (UFF), Nitero´i, Brazil; 2Asociac¸a˜o Carioca de Assistencia a`
Mucoviscidose (ACAMRJ), Rio de Janeiro, Brazil
Introduction: Education of relatives of patients with cystic ﬁbrosis is quite relevant
for the complexity of its treatment that is often not well understood by parents during
the consultation hospital.
Objective: To evaluate the clinical aspect of children with cystic ﬁbrosis before
and after the educational intervention on respiratory care.
Methods: We conducted a randomized controlled trial using spirometry test as a
parameter for randomization. The study included 35 caregivers of patients aged
6−13 years enrolled in ACAMRJ and results of mild or moderate obstruction in
spirometry test. After assessment, the caregivers in the experimental group received
four home visits. At the end of the intervention, all participants were reassessed.
Analysis: Quantitative data with a normal distribution were analyzed by analysis
of variance. The test of Pearson product moment correlation was used for variables
with normal distribution, and the Spearman correlation coefﬁcient for variables
without normal distribution.
Results: In this study we found that 57% of children did not perform respiratory
therapy, 63% did not exercise, 37% were colonized with Pseudomonas aeruginosas
and 17% were homozygous DF508. Insofar assessment of expiratory ﬂow, the
experimental group had a mean change of around 29% for the control group and
the experimental group in the evaluation had less variation than the control group
emphasizing the effectiveness of the experiment.
Conclusion: Although some studies on education are identiﬁed, none of them
performed this type of intervention.
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Objectives: Spirotiger® device trains respiratory muscles throughout isocapnic
hyperpnea. Device setup has been prompted on parameters derived by healthy
subjects.
Aim: To evaluate differences in the setup between derived formula and CF patients
measured parameters.
Methods: 47 CF patients in clinically stable conditions were enrolled. RR, MVV,
RMV (Respiratory Minute Volume) and the required bag volume have been
compared with standard and empiric formulas. Sample was described and processed
using Wilcoxon matched-pairs signed-ranks test with signiﬁcance set at 5%.
Results: Patient age ranged 18−45 yrs (25±37.47) with mean BMI
21.20±2.65 kg/m2. Mean predicted %FEV1 was 73.53±24.9. Through standard
formulas as provided by the manufacturer, a mean MVV of 138.49±410.99 l/min,
a mean RMV of 83.09±6.59 l/min, a mean bag volume of 2.36±0.26 l and
a mean RR of 27.80±9.75 were found. Through the empirical setup, mean
MVV was 106.04±43.88 l/min, mean RMV was 63.62±26.33 l/min, mean bag
volume1.77±0.55 and mean RR 28.04±9.63. Difference of means between standard
and empiric formulas for RR (p = 0.83) was not statistically signiﬁcant, while for
MVV (p< 0.0001), RMV (p< 0.0001) and the bag volume (p< 0.0001) means were
statistically different. Mean differences were not closed to zero for RMV and MVV,
respectively −19.46 l/min and −32.44 l/min thus arguing an overall distortion that
might have clinical impact.
Conclusion: Given such differences, standard and empirical formulas need to be
tested not only on patients with CF but also with other pulmonary disease. In
order to assess whether Spirotiger® could have some effects on respiratory muscle
training, further studies are required taking into account such variability.
227 The use of nasal high ﬂow humidiﬁcation with cystic ﬁbrosis
patients − A pilot
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Background: Delivery of adequate humidiﬁcation for patients requiring Oxygen
(O2) therapy is challenging. Many patients ﬁnd face masks uncomfortable and
restrictive preferring nasal cannula (NC). However prolonged use of NC particularly
at higher ﬂow (>3 l/min) can contribute to drying of the mucosal membrane and
epistaxis. Patients with Cystic Fibrosis (CF) may struggle to expectorate viscous
secretions even when using mucolytics. This can be exacerbated by other factors
such as dehydration or diabetes. Airvo™ Nasal High Flow Therapy (NHF) offers
heated humidiﬁcation via a nasal interface at high ﬂow.
Method: Our CF Unit has piloted NHF for the past year with a view to purchasing
further units. We wished to look at potential effects on Airway Clearance and
patient’s comfort. Admissions were for exacerbation of respiratory symptoms, IV
Antibiotics and O2 therapy. Patients were surveyed and common themes identiﬁed.
Results: 17 patients over 30 episodes of care (7 to >28 days) with a range of
O2 requirements (FiO2 0.28–0.55), ﬂow ranges from 15−40 l/min. 16/17 (94%)
tolerated NHF. Patients reported it to be comfortable, easy to use, not interfering
with communication or eating. Subjectively reporting increased expectoration,
decreased sputum viscosity − supported objectively by physiotherapists.
Conclusions: NHF has proved a useful and popular additional treatment adjunct,
with patients requesting to use it on subsequent admissions. It can also provide
NHF on room air giving patients the beneﬁt of heated humidiﬁcation with no O2
requirement. We plan to do a longer term study using this system.
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Objectives: To get children and staff at Bristol Paediatric CF centre to undertake
an exercise challenge to increase their daily step count and undertake more periods
of active exercise per week; with emphasis on personalised targets and being part
of a group activity.
Methods: All school aged children and staff in the CF MDT were invited to take
part in a 4 week challenge in the run up to the 2012 Olympic games. It had 2 parts.
The daily step challenge − using a pedometer to record steps/day. Week 1 was used
a baseline with all participants aiming for 10,000 steps/day. For subsequent weeks
a personal step target was set using the previous weeks data. The weekly sports
star challenge − recording the number of times that vigorous activity or sport was
undertaken/week. Participants were awarded a sports star each week according to
the number of vigorous activities undertaken. All participants were contacted at the
end of each week to record their data and set a revised step target. Our website was
utilised allowing all participants to monitor their progress. A weekly newsletter and
blog page were posted to encourage interaction with others. All participants data
was anonymised.
Conclusion: Those actively involved steadily increased their step target over the
challenge with 70% having increased targets in week 4 and the number undertaking
2 or more sports/week increased to 100% by week 4. Those doing 4 or more sports
increased to 80%. Interaction via the website was well received. Those under 8 yrs
struggled to wear pedometers. The challenge sucessfully encouraged increased daily
activity and participation in vigorous exercise.
